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Abstract
Objective—We previously reported the expression of the 2-pore domain K+ channel TREK-1 in
lung epithelial cells and proposed a role for this channel in the regulation of alveolar epithelial
cytokine secretion. In this study we focused on investigating the role of TREK-1 in vivo in the
development of hyperoxia-induced lung injury.
Design—Laboratory animal experiments.
Setting—University research laboratory.
Subjects—Wild type and TREK-1 deficient mice.
Interventions—Mice were anesthetized and exposed to 1) room air, no mechanical ventilation,
2) 95% hyperoxia for 24 hours, 3) 95% hyperoxia for 24 hours followed by mechanical ventilation
for 4 hours.
Measurements and Main Results—Hyperoxia exposure accentuated lung injury in TREK-1
deficient mice but not controls, resulting in increased in Lung Injury Scores (LIS), broncho-
alveolar lavage (BAL) fluid cell numbers and cellular apoptosis, and a decrease in quasi-static
lung compliance. Exposure to a combination of hyperoxia and injurious mechanical ventilation
resulted in further morphological lung damage, increased LIS and BAL fluid cell numbers in
control but not TREK-1 deficient mice. At baseline and after hyperoxia exposure BAL cytokine
levels were unchanged in TREK-1 deficient mice compared to controls. Exposure to hyperoxia
and mechanical ventilation resulted in an increase in BAL IL-6, MCP-1 and TNF-α levels in both
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mouse types, but the increase in IL-6 and MCP-1 levels was less prominent in TREK-1 deficient
mice than in controls. Lung tissue MIP-2, KC and IL-1β gene expression was not altered by
hyperoxia in TREK-1 deficient mice compared to controls. Furthermore, we show for the first
time TREK-1 expression on alveolar macrophages and unimpaired TNF-α secretion from TREK-1
deficient macrophages.
Conclusion—TREK-1 deficiency resulted in increased sensitivity of lungs to hyperoxia but this
effect is less prominent if overwhelming injury is induced by the combination of hyperoxia and
injurious mechanical ventilation. TREK-1 may constitute a new potential target for the
development of novel treatment strategies against hyperoxia-induced lung injury.
Keywords
TREK; lung; lung injury; acute respiratory distress syndrome; ARDS
INTRODUCTION
Acute Respiratory Distress Syndrome (ARDS) remains a challenging disease to manage in
both the adult and pediatric populations[1, 2] and is still associated with significant mortality
and morbidity rates[3]. The main treatment strategies against ARDS, mechanical ventilation
and oxygen supplementation[4], are life-saving therapies, but unfortunately the
proinflammatory effects of hyperoxia (HO) and mechanical stretch promote further lung
injury and can be reproduced in both in vitro and in vivo models of ARDS[5-8]. Therefore,
the development of new therapeutic strategies against ARDS represents a major research
interest.
While our own group[9, 10] and others[11, 12] confirmed the detrimental effects of HO on
lung tissue and documented the time course of HO-induced lung inflammation[13], the
contribution of ion channels, in particular 2-pore domain potassium (K2P) channels
including TREK-1, to the development of ARDS remains unclear. To date, the main
function of K2P channels is thought to consist in regulation of the resting cell membrane
potential[14-16] by sustaining so-called “background” or “leak” potassium currents, and
little is known about other potential functions of K2P channels. We previously suggested
that the K2P channel TREK-1 may play a regulatory role in the development of alveolar
epithelial injury. We found that TREK-1 deficiency altered the cytokine release profile of
alveolar epithelial cells upon TNF-α stimulation, resulting in decreased IL-6 and increased
MCP-1 secretion[17, 18]. Although activation of several TNF-α induced signaling
pathways, including p38 kinase and the PKCθ isoform, appeared altered in TREK-1
deficient epithelial cells, the specific regulatory mechanisms underlying these signaling
changes remains unclear.
Since the pathological processes leading to ARDS affect not only the alveolar epithelium but
rather the lung as a whole, in this study we investigated the effects of HO in vivo using a
TREK-1 deficient mouse model. To the best of our knowledge, the only other studies
describing K2P channels in the lung suggested a role for these channels in bronchial Na+
and Cl− transport[19] and in mucosal gland secretion[20]. We show for the first time that
exposure of TREK-1 deficient mice to HO resulted in an increase in inflammatory
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parameters, including higher lung injury scores, worsening of quasi-static lung compliance,
and increased cellular apoptosis, which was independent of BAL fluid cytokine levels and
cytokine gene expression in the lung tissue. Overall, our results suggest that the K2P
channel TREK-1 may play an important role in the development of HO-induced lung injury.
MATERIALS AND METHODS
Animals
C57BL/J6 wildtype (WT) mice, aged 8-10 weeks were obtained from Charles River
Laboratories (Wilmington, MA). Age-matched TREK-1 ko mice were obtained from an
existing colony at Baylor College of Medicine (Texas Genetic Institute)[21], and all
experiments were performed in accordance with the animal protocols approved by the
University of Tennessee Health Science Center and Baylor College of Medicine.
Ventilation protocol
Mice were divided into 3 experimental groups: 1) room air, no mechanical ventilation, 2)
exposure to 95% HO for 24 hours using an HO chamber (BioSpherix), and a ProOx C21
O2/CO2 controller (BioSpherix), 3) exposure to 95% HO for 24 hours followed by injurious
mechanical ventilation (MV) for 4 hours using the Flexivent system (SQIREC; tidal volume
25ml/kg, RR 60 breaths/min, PEEP 2mmH2O). These conditions have consistently proven
to be injurious and result in a phenotype similar to the one observed in patients with
ARDS[9, 10]. Adequate anesthesia was provided with an intraperitoneal injection of a
ketamine/xylazine mixture (1:1, 0.15mL/10grams body weight), and 1% inhaled isofluorane
using a precision gas mixer (PEGAS 400, Columbus Instruments, OH). MV was provided
using the Flexivent system via a tracheostomy with an 18 gauge needle. Quasi-static lung
compliance was measured under general anesthesia. Mice in groups 1) and 2) were
sacrificed after quasi-static compliance was recorded, and mice from group 3 were
ventilated as described above. Pressure-volume curves (P-V) were recorded at the beginning
and the end of each experiment. Each set of P-V curves was preceded by two inflation
maneuvers to total lung capacity to insure equal standard volumes for each experiment.
Rectal temperature was maintained within the normal range using a heat lamp. At the end of
mechanical ventilation a second lung compliance measurement was performed and values
were calculated by fitting data derived from the P-V curves to the Salazar-Knowles equation
as previously described[22]. In addition, mice were given intraperitoneal injections of 100 μl
of saline every hour on the ventilator to maintain an isovolemic fluid balance by correcting
for insensible losses. At the end of the experiment, mice were sacrificed by cardiac puncture
and a 4% isofluorane overdose.
Sample collection
Using three 1ml syringes, bronchoalveolar lavage (BAL) was performed using 3× 1ml PBS
with 0.6mM EDTA. Cytospins were prepared using BAL fluid to perform differential cell
counts as previously described[9]. Total cell counts were calculated from BAL fluid using a
hemocytometer after 1:1 mix with Turk's solution. From the rest of the BAL fluid, total
protein concentrations were measured and the remainder was used for cytokine analysis by
ELISA. The heart and lungs were removed en bloc, retrograde perfused with 5ml PBS to
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remove red blood cells, and photographs were taken of the lungs. Tissue samples for
confocal microscopy were immediately frozen on dry ice, tissue samples for Western blot
analysis were placed in RIPA buffer (50 mM Tris·HCl, pH 7.4, 150 mM NaCl, 2 mM
EDTA, 1% Nonidet P-40, 0.1% SDS) containing a protease inhibitor cocktail (Roche,
Burlington, NC) on ice and stored at −80°C. Tissue samples for RT-PCR were frozen in
RNA lysis buffer (Agilent Technologies).
Lung histology
After retrograde perfusion of the lungs, lung tissue was harvested and processed for
histological examination as described previously[10]. To determine Lung Injury Scores
(LIS), a pathologist blinded to the experimental conditions assigned a 5-parameter LIS (1.
Interstitial edema, 2. alveolar edema, 3. neutrophil infiltration, 4. parenchymal hemorrhage
and 5. perivascular-peribronchial hemorrhage) to each H&E stained lung section by
examining 4 high power fields (40× magnification) per slide. Each criterion was assigned a
score from 0-4 points with 0 points representing no injury and 4 points representing severe
lung injury. The histological composite LIS in Figure 1C represents the mean value of the 5
parameters for each mouse.
BAL fluid cytokine measurements by ELISA
TNF-α, IL-6 and MCP-1 levels in BAL fluid were quantified using BD Bioscience OptEIA
species-specific ELISA kits following the manufacturer's instructions. Briefly, BAL was
performed as described above by lavaging each lung 3 times with 1ml of PBS. The 3
aliquots were combined and supernatants were collected after ultracentrifugation at 8,000
rpm for 5 min. For cytokine measurements, 100μL of BAL supernatant was loaded into a 96
well ELISA plate. All samples were run in triplicates. Cytokine amounts were displayed in
pg/mL.
Cytokine gene expression by RT-PCR
Total RNA was isolated from whole lung homogenates using an Absolutely RNA Miniprep
kit (Agilent Technologies) according to the manufacturer's instructions. Contaminating
genomic DNA was removed by treatment with DNA-free (Ambion, Austin, TX) according
to the manufacturer's directions. Single-stranded DNA was synthesized from 1μg total RNA
and RT-PCR was performed using a Transcriptor First Strand cDNA kit (Roche) according
to the manufacturer's instructions and then amplified with Tag polymerase for 30–35 cycles
in an Eppendorf Mastercycler EP Thermal Cycler using primers specific for each cytokine.
The following primer sequences were used: MIP-2 forward: TGG GTG GGA TGT AGC
TAG TTC C, MIP-2 reverse: AGT TTG CCT TGA CCC TGA AGC C; KC (CXCL1)
forward: AAC GGA GAA AGA AGA CAG ACT, KC (CXCL1) reverse: GAC GAG ACC
AGG AGA AAC AG. IL-1β forward: CAG GAT GAG GAC ATG AGC ACC, IL-1β
reverse: CTC TGC AGA CTC AAA CTC CAC; The housekeeping gene β-actin was used as
an internal control. After amplification, 16 μL of each reaction mixture was separated by
electrophoresis on 1.8% agarose gels and the bands visualized by ethidium bromide staining.
The pictures shown are representative of 3 experiments.
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Alveolar macrophages (AM) were recovered from the BAL fluid from untreated mice as
described previously[23]. AMs (2×105 cells/well) were stimulated with 0 or 1 ng/ml LPS
and culture supernatants were collected following 24 hour incubation at 37°C for TNF-α
production as measured by ELISA (BD Bioscience).
Macrophage immunofluorescence staining
AMs were collected from BAL fluid and 30,000 cells were spun onto a glass slide. Cells
were washed with PBS and fixed with IC Fixation buffer (eBioscience) for 20 min at room
temperature. The cells were then washed with PBST (PBS with 0.05% Tween-20) and
incubated with Dako protein block (Dako, Carpinteria, CA) for 30 min at room temperature.
Cells were washed again in PBST and incubated for 1 hour with an anti-TREK-1 antibody
(C-20, 1:50 dilution in PBST, 1% BSA, Santa Cruz Biotech). After an additional washing
step, cells were incubated for 1 hour with a secondary, biotinylated rabbit anti-goat antibody
(1:150 in PBST with 1% BSA, Vector Labs) at room temperature. Thereafter, cells were
washed again and then incubated for 1 hour with streptavidin-Cy3 (1:750 in PBST in
1%BSA, Jackson Immuno, West Grove, PA) at room temperature in the dark. After an
additional washing step, the slides were dried and coverslips were mounted with Vectashield
+DAPI (Vector labs). Images were taken on an EVOS FL Auto (Life Technologies)
instrument.
Confocal Microscopy
After resection, lungs were immediately fixed in 4% formalin, and paraffin-embedded
sections were cut into 4 μm thick tissues slices using a Microtome. TUNEL staining was
performed according to the manufacturer's instructions using a fluorescence-based In Situ
Cell Death Detection kit (Roche). Nuclear staining was obtained using Fluoro Gel II
mounting medium containing DAPI (Electron Microscopy Sciences, Hatfield, PA). Images
were acquired using the Zeiss 710 confocal imaging system available in the Department of
Physiology at UTHSC. Emitted fluorescence was collected using a 20× magnification
objective lens (NA 1.4 Oil), and the images were recorded using Zen 2009 Light Edition
software (Zeiss).
For double stained lung sections, we used the TUNEL assay protocol as above and
subsequently stained lung slices of TREK-1 deficient mice exposed to HO, or HO+MV with
an anti-proSPC antibody (Millipore, Billerica, MA; 1:300; 24 hours at 4°C) to identify type
II pneumocytes, or an anti-Aquaporin-5 antibody (Alamone Labs, 1:100; room temperature
for 2 hours). Lung slices were then washed 3 times, and a species specific Alexa Fluor 594
secondary antibody was applied for 1 hour at room temperature. Slices were then mounted
in Fluoro Gel II mounting medium with DAPI (EMS, Hatfield, PA) and analyzed as
described above.
Western Blot Analysis
Frozen lung tissue was thawed on ice and whole lung homogenates were prepared using a
tissue homogenizer in RIPA buffer containing the protease inhibitor cocktail. Homogenates
Schwingshackl et al. Page 5






















were centrifuged at 17,000 g for 15 min at 4°C, and total protein concentrations were
determined using the Bradford assay (BioRad, Hercules, CA). A total of 50 μg protein of
each sample was separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE) on 4-12% NuPage Bis-Tris gradient gels (Invitrogen) and
transferred onto nitrocellulose membranes at 35 mV for 2 hours. Membranes were blocked
in 5% non-fat dry milk in Tris-buffered saline (Bio-Rad) containing 0.1% Tween-20 (TBST)
for 1 h at 37°C. The membranes were then incubated overnight with an anti-cleaved PARP-1
antibody (Cell Signaling, 1:1000) or an anti-total PARP-1 antibody (Cell Signaling, 1:1000)
at 4°C. The next day, after 3 washing steps in TBST, all membranes were incubated for 1
hour at room temperature with an anti-rabbit HRP-conjugated IgG antibody (1:3000, Cell
Signaling). Bands were visualized by enhanced chemoluminescence with ECL SuperSignal
West Dura Extended Duration Substrate (Thermo Scientific, Rockford IL). Band
densitometry measurements to determine relative quantities of protein were performed using
ImageJ 1.42 software for Windows.
Statistical Analysis
All values were expressed as means±SEM. Data were analyzed using 2×3 (2 mouse types, 3
experimental conditions) ANOVA models, and pairwise comparison of the means were
tested using the Tukey-Kramer method to adjust for multiple comparisons. For some of the
BAL cytokines, transformations were used when residuals from the models were not
normally distributed. All statistical analyses were performed using StatPlus software and
SAS/STAT® software, and a p-value of p<0.05 was considered significant. (*) represents
groups of mice compared to untreated WT control; (#) represents groups of mice compared
to untreated TREK-1 ko control. (^) represents comparisons of WT to TREK-1 ko mice
within the same treatment group.
RESULTS
Hyperoxia caused increased lung damage in TREK-1 deficient lungs
We previously proposed a role for TREK-1 in cytokine secretion from alveolar epithelial
cells[17, 18] and now investigated whether TREK-1 also plays a role in an in vivo model of
hyperoxia (HO)-induced lung injury. We exposed WT and TREK-1 deficient mice to either
24 hours of HO alone, or 24 hours of HO followed by 4 hours of injurious mechanical
ventilation (MV) and analyzed lung morphology (Figure 1A), lung histology (Figure 1B),
and a 5-point composite lung injury score (LIS) from each section (Figure 1C). We found
that at baseline both untreated WT and TREK-1 deficient mice showed normal, uninjured
lung morphology and histology, which was confirmed by a low LIS in both animal groups.
HO exposure for 24 hours resulted in no significant lung damage in WT mice but in
increased morphological and histological injury in TREK-1 deficient mice, which was also
reflected by an increased LIS in HO-treated TREK-1 deficient mice when compared to
untreated TREK-1 deficient mice. Since we knew from our previous studies that pre-
exposure of WT mice to HO+MV resulted in additional lung injury[10], we investigated
whether this would also occur in TREK-1 deficient animals. Interestingly, when compared
to HO alone, exposure to HO+MV led to a further increase in morphological and
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histological lung injury in WT but not TREK-1 deficient mice, which was also reflected in
the LIS of these groups.
HO increased BAL cell counts but not protein levels in TREK-1 deficient mice
To further characterize the proinflammatory phenotype observed in TREK-1 deficient lungs
exposed to HO, we quantified total (Figure 2A) and differential BAL fluid cell counts
(Figure 2B) and measured total BAL fluid protein levels (Figure 2C). Exposure of mice to
HO resulted in an increase in the total number of cells in the BAL fluid recovered from
TREK-1 deficient mice but not from WT mice. Exposure to HO+MV led to a further
increase in the total number of cells in the BAL fluid of WT but not TREK-1 deficient mice.
Analysis of BAL fluid differential cell counts showed a relative increase in the percentage of
neutrophils in TREK-1 deficient but not WT mice exposed to HO. Exposure to HO+MV
caused a similar relative increase in the percentage of neutrophils in both mouse types.
In contrast to cell numbers in the BAL fluid of TREK-1 deficient mice, total protein levels
were not significantly increased in either WT or TREK-1 deficient mice after HO treatment.
Exposure to HO+MV increased total BAL fluid protein levels to a similar degree in both
WT and TREK-1 deficient mice when compared to untreated and HO-treated mice.
HO exposure decreased quasi-static lung compliance in TREK-1 deficient mice
We previously found that exposure of mice to HO+MV resulted in a decrease in quasi-static
lung compliance[10], which is a measure of the elastic recoil pressure of the lungs at a given
lung volume and correlates with worsening lung injury in both patients and in animal
models of lung injury[24, 25]. We now investigated whether the lung damage observed in
TREK-1 deficient mice exposed to HO was also reflected by a decrease in quasi-static lung
compliance. We found that HO exposure decreased quasi-static lung compliance in TREK-1
deficient mice but not in WT mice (Figure 3). Exposure to HO+MV further decreased quasi-
static lung compliance in both WT and TREK-1 deficient mice but no difference in quasi-
static lung compliance was observed between the two mouse types under these conditions.
Exposure of TREK-1 deficient mice to HO had no effect on BAL fluid TNF-α, IL-6 and
MCP-1 levels
To determine whether the increased cell counts and decreased quasi-static compliance in
TREK-1 deficient mice correlated with alterations in BAL fluid cytokine secretion, we
measured TNF-α, IL-6 and MCP-1 levels in WT and TREK-1 deficient mice (Figure 4A).
Exposure of both mouse types to HO alone had no effect on BAL fluid cytokine levels when
compared to untreated animals. Exposure to HO+MV increased BAL fluid TNF-α, IL-6 and
MCP-1 levels in both WT and TREK-1 deficient mice. However, while TNF-α levels
increased to a similar degree in WT and TREK-1 deficient mice after exposure to HO+MV,
IL-6 and MCP-1 levels increased to a lesser degree in TREK-1 deficient mice than in
controls.
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Exposure of TREK-1 deficient mice to HO had no effect on whole lung MIP-2, KC and IL-1β
gene expression levels
Using conventional RT-PCR, we measured gene expression of the inflammatory cytokines
MIP-2, KC and IL-1β in whole lung homogenates of WT and TREK-1 deficient mice
(Figure 4B). We detected neither MIP-2 nor KC mRNA at baseline or after 24 hours of HO
exposure in WT or TREK-1 deficient mice. Exposure of both WT and TREK-1 deficient
mice to 24 hours HO followed by 4 hours of MV induced equal levels of MIP-2 and KC
gene expression in both mouse types. In contrast, we detected IL-1β gene expression in
untreated TREK-1 deficient animals but not WT mice. However, after exposure of mice to
HO or HO+MV no further differences in IL-1β gene expression were observed between WT
and TREK-1 deficient mice.
Macrophage activation was intact in TREK-1 deficient mice
To evaluate whether the increase in lung injury observed in TREK-1 deficient mice was
related to alterations in macrophage activation in these animals, we isolated alveolar
macrophages (AMs) from WT and TREK-1 deficient mice (Figure 5). We first investigated
whether AMs from untreated WT mice expressed TREK-1 protein using
immunofluorescence staining (Figure 5A). In fact, AMs showed both intracellular and
membrane bound TREK-1 protein staining. In addition, since we knew from our in vitro[18]
as well as our in vivo studies (Figure 4) that HO is a weak stimulus for cytokine release, we
stimulated AMs with LPS and measured TNF-α secretion (Figure 5B). Baseline secretion of
TNF-α was low in WT and TREK-1 deficient animals but after LPS stimulation both WT
and TREK-1 deficient mice showed and an equal increase in TNF-α release. Based on these
results, AM activation appeared intact in TREK-1 deficient mice.
TREK-1 deficiency promoted apoptosis in HO exposed lungs
We previously reported that exposure of lungs to HO+MV activated pro-apoptotic signaling
cascades resulting in increased levels of cleaved poly [ADP-ribose] polymerase-1 (PARP-1)
[9]. To determine whether cellular apoptosis was increased in TREK-1 deficient mice, we
performed Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL)
staining of lung sections and measured PARP-1 activation in whole lung homogenates. HO
exposure induced cellular apoptosis as indicated by an increase in TUNEL positive cells in
TREK-1 deficient but not in WT mice when compared to untreated mice (Figure 6A).
Exposure to HO+MV increased cellular apoptosis in both WT and TREK-1 deficient mice,
but the effect was more pronounced in TREK-1 deficient mice. Quantification of the number
of TUNEL positive cells per field is summarized in Figure 6B. To determine the identity of
TUNEL positive cells, we double-stained lung sections of TREK-1 deficient animals
exposed to HO and HO+MV using the TUNEL assay and an anti-pro-SPC antibody to label
type II pneumocytes (Figures 7A and B). In addition, we also double stained lung sections of
TREK-1 deficient animals exposed to HO+MV with TUNEL assay and an Aquaporin-5
antibody, a marker of alveolar type I pneumocytes (Figure 7C). The inserts of the confocal
images, cell size and location demonstrate both apoptotic type II cells (TUNEL and pro-SPC
positive) and type I cells (TUNEL and Aquaporin-5 positive). However, we cannot exclude
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the possibility that some of the TUNEL positive but pro-SPC or Aquaporin-5 negative cells
were endothelial cells or fibroblasts.
Similarly to TUNEL staining, HO exposure induced PARP-1 cleavage in TREK-1 deficient
but not in WT mice when compared to untreated mice (Figure 8A). Exposure to HO+MV
caused a further increase in PARP-1 activation in both WT and TREK-1 deficient mice.
Quantification of cleaved to total PARP-1 ratios by band densitometry is summarized in
Figure 8B.
DISCUSSION
We recently reported the expression of K2P channels in alveolar epithelial cells (AECs) and
found that TNF-α stimulation of TREK-1 deficient AECs caused decreased IL-6 secretion
but increased MCP-1 secretion in vitro[17, 18]. Therefore, we were interested in
determining whether in vivo TREK-1 deficiency would ultimately promote a pro- or anti-
inflammatory phenotype. In this study we show for the first time in an in vivo model of
ARDS that TREK-1 may play an important role in the development of hyperoxia (HO)-
induced lung injury. We found that exposure of TREK-1 deficient mice to HO resulted in
increased lung injury at morphological and histological levels, which translated into a
decrease in quasi-static lung compliance and activation of proapoptotic signaling pathways
in TREK-1 deficient animals. Interestingly, the combination of HO and mechanical
ventilation (MV) caused further injury in WT animals but not in TREK-1 deficient mice,
and the differences in Lung Injury Score (LIS), BAL fluid cell count and lung compliance
observed between control and TREK-1 deficient mice exposed to HO were no longer visible
once severe injury was induced by mechanical ventilation. Therefore, it appears that
TREK-1 may play a more prominent role in HO-than in stretch-induced lung injury, but the
role of TREK-1 in isolated stretch-induced injury clearly needs further evaluation. However,
a clinical scenario where a patient with ARDS would be ventilated with room air is unlikely,
since hypoxia is one of the defining criteria of ARDS[26]. Therefore, for the purpose of this
study, we did not pursue the isolated effects of mechanical ventilation further. We chose the
24 hour time point of HO exposure based on published literature reporting an oxidative
stress-induced inflammatory response similar to ours in a lung injury model[13].
Our studies are the first to link TREK-1 to the development of lung injury, but the main
question remaining is how TREK-1 deficiency promotes HO-induced injury in vivo. The
increased number of inflammatory cells found in the BAL fluid of HO-exposed TREK-1
deficient mice without an increase in BAL fluid protein suggests increased inflammatory
cell infiltration without a significant loss of alveolar barrier function (Figure 2). An
increased number of inflammatory cells was also observed in the lung interstitium of HO-
exposed TREK-1 deficient mice by histology (Figure 1). The majority of cells entering the
BAL fluid were neutrophils but we also saw increased numbers of macrophages in BAL
fluid of TREK-1 deficient mice after HO exposure. In addition, we observed small numbers
of lymphocytes and occasional epithelial cells in the BAL fluid from the TREK-1 deficient
mice (data not shown). It is likely that these cells, as well as monocytes and dendritic cells,
contribute to the total BAL cell number in TREK-1 deficient mice compared to WT mice.
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Interestingly, in contrast to inflammatory cell infiltration, BAL fluid levels of TNF-α, IL-6
and MCP-1, as well as gene expression of MIP-2, KC and IL-1β, were not altered in HO-
exposed TREK-1 deficient mice (Figures 4A and B). Several reasons may explain why we
observed an increase in neutrophils, and to a lesser degree of macrophages and lymphocytes,
without changes in the cytokines tested. It is certainly possible that the recruitment of
neutrophils and other inflammatory cells may be stimulated by BAL fluid or interstitial
cytokines not measured in this study (such as GRO-α, G-CSF, C5a, LTB4, NAP-2,
CINC-2α, IL-17 for neutrophils, and RANTES, MIP-1a/b, MIP-3 for macrophages)[27-30].
In addition, changes in cytokine levels may have occurred prior to the lung damage observed
after 24 hours of HO exposure. Furthermore, whole lung homogenates and BAL fluid may
severely underestimate the local production and secretion of cytokines and the inflammatory
changes occurring in the micro-milieu of the alveoli and the lung interstitium. We addressed
some of these questions by isolating alveolar macrophages and studying their activation
profile (Figure 5). Importantly, we also showed for the first time expression of TREK-1 in
macrophages. The weak cytokine response to HO exposure is similar to our in vitro findings
in alveolar epithelial cells, where HO alone did not induce significant IL-6, MCP-1 or
RANTES release[18]. Consistent with our previous in vitro findings in Trek-1 deficient
AECs[17], injury caused by HO+MV resulted in decreased IL-6 levels in the BAL fluid of
Trek-1 deficient mice. However, MCP-1 levels were also decreased in the BAL fluid of
Trek-1 deficient mice, whereas in vitro MCP-1 secretion was increased from Trek-1
deficient AECs[31]. Altogether, these data suggest that 1) TREK-1 deficiency may have a
different effect on cytokine secretion from cultured AECs than in whole lung tissue, and 2)
TREK-1 may play a role in the regulation of inflammatory cell infiltration upon HO
exposure without significant changes in alveolar barrier function and BAL cytokine levels,
whereas after exposure to HO+MV TREK-1 deficiency regulates BAL fluid IL-6 and
MCP-1 but not TNF-α concentrations. Similar to our previous study using cultured alveolar
epithelial cells[18] we found no effect of TREK-1 deficiency on KC production despite
observing increased neutrophil influx after HO treatment Again, it is possible that KC gene
expression peaked much earlier than the 24 hour time point, and thus KC could still be
important for neutrophil recruitment. In the future, a more detailed time course of KC
expression could aid in determining the role of this chemokine in the observed lung injury in
TREK-1 deficient mice.
Interestingly, the decrease in BAL fluid IL-6 and MCP-1 levels was associated with
increased cellular apoptosis in TREK-1 deficient mice exposed to HO+MV. Previous studies
have suggested that IL-6 is a multifunctional cytokine with time-, dose-and organ-specific
functions[32]. For example, IL-6 is known to decrease T cell apoptosis and promote
epithelial survival in the GI system[33], and to ameliorate lung injury by re-establishing
surfactant levels[34]. Similarly, MCP-1 is known to play a protective role in bleomycin-
induced lung injury[35]. It is possible that the increased levels of cellular apoptosis observed
after HO+MV are related to the decreased IL-6 and MCP-1 levels in TREK-1 deficient mice
but certainly, as mentioned above, several other mediators not tested in this study could also
be involved. Ideally, direct comparisons between BAL fluid and interstitial cytokine levels
would aid in answering these difficult questions, but such experiments are technically
challenging. To start addressing these questions, we studied gene expression of MIP-2, KC
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and IL-1β in whole lung tissue and found no significant differences between WT and
TREK-1 deficient mice after HO or HO+MV exposure. Interestingly, we found IL-1β
expression in untreated TREK-1 deficient mice but not in WT mice, potentially suggesting a
baseline activation of the inflammasome in these mice. Although we cannot exclude some
type of systemic immunodeficiency in TREK-1 deficient mice resulting in decreased IL-6
and MCP-1 levels and increased sensitivity to HO, LPS–induced activation of alveolar
macrophages appeared intact in TREK-1 deficient animals. Whether this also holds true for
interstitial macrophages is currently under investigation. In addition to macrophages, T cell
mediated responses could be altered by systemic TREK-1 deficiency. Furthermore, while we
are the first group to show TREK-1 expression in macrophages, the presence of TREK-1-
related channels (TREK-2 and TASK-2) on lymphocytes has been reported previously [36,
37]. Furthermore, isolation of type II pneumocytes from TREK-1 deficient mice will allow
us in future experiments to determine whether alterations in epithelial cell activation are
contributing to the increased sensitivity to HO in these mice. Another important point to
address in future studies is whether the effects of TREK-1 deficiency are related to
alterations in cellular K+ handling, or whether TREK-1 can exert functions that are unrelated
to its role as a K+ channel as for example described for CFTR[38, 39]. In a recently
published study[40] we showed that TREK-1 regulates the mechanobiological properties of
AECs by altering F-actin metabolism and overall cellular stiffness. We are also in the early
stages of developing a conditional TREK-1 knockout model to study the effects of this
channel specifically in the alveolar epithelium, and to integrate our in vivo data with the
results obtained with cultured AECs[17, 18].
In conclusion, although we have previously suggested a potential role for TREK-1 in the
development of alveolar epithelial injury in vitro, this is the first report showing that
TREK-1 deficiency accentuates HO-induced lung injury in vivo. This lung injury is
evidenced by decreased compliance, increased pulmonary inflammatory infiltrates including
neutrophils, macrophages, and lymphocytes, and an increase in apoptotic cells. It appeared
that with the combination of 24 hours HO + 4 hours injurious MV maximal lung injury was
achieved and differences between WT and TREK-1 deficient mice were less readily
apparent. Clinically, this suggests that in vivo TREK-1 may play an important role in
preventing or modulating moderate HO-induced lung injury but is insufficient to protect
against severe lung injury.
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Figure 1. TREK-1 deficient mice were more sensitive to hyperoxia (HO)
Panel A shows representative lung photographs of wildtype (WT) and TREK-1 deficient
(TREK-1 ko) mice exposed to either normoxia and no mechanical ventilation (MV), 24
hours of 95% HO, or 24 hours of 95% HO followed by 4 hours of injurious MV. Similarly,
Panel B shows representative H&E stained lung sections of mice exposed to the conditions
described in Figure 1A. Panel C shows a summary of the composite lung injury scores (LIS)
assigned to each section. (* compared to untreated WT control; # compared to untreated
TREK-1 ko control; n=4-7 animals per group).
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Figure 2. HO exposure increased the total cell number but not protein levels in the BAL fluid of
TREK-1 deficient mice
Panel A: Exposure to HO increased the total BAL cell count in TREK-1 deficient mice but
not in WT mice. After exposure to HO+MV total BAL cell counts were increased to a
similar degree in WT and TREK-1 deficient mice. Panel B shows analysis of differential cell
counts from BAL fluid. Panel C: Exposure to HO alone did not affect BAL protein levels in
either WT or TREK-1 deficient mice when compared with untreated controls. Exposure to
HO+MV increased total BAL protein levels in both WT and TREK-1 deficient mice when
compared to untreated or HO exposed mice. *compared to untreated WT control; #
compared to untreated TREK-1 ko control; n=4-7 animals per group.
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Figure 3. HO exposure decreased quasi-static lung compliance in TREK-1 deficient mice
HO exposure (24 hrs) decreased quasi-static lung compliance in TREK-1 but not WT mice.
Exposure to HO+MV further decreased quasi-static lung compliance in both WT and
TREK-1 deficient mice to a similar level. *compared to untreated WT control; #compared to
untreated TREK-1 ko control; n=6-10 animals per group.
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Figure 4. TREK-1 deficiency altered BAL fluid cytokine levels after HO+MV exposure but not
after HO alone
HO exposure alone did not affect TNF-α, IL-6 or MCP-1 secretion in either WT or TREK-1
deficient mice (Panel A). Although exposure to HO+MV increased BAL fluid levels of all 3
cytokines, the increase in TNF-α was equal between WT and TREK-1 deficient mice,
whereas the increase in IL-6 and MCP-1 was diminished in TREK-1 deficient mice
compared to WT mice. *compared to untreated WT control; #compared to untreated
TREK-1 ko control; n=4-8 animals per group. Neither HO nor HO+MV affected MIP-2, KC
or IL-1β gene expression in whole lung homogenates using PCR (Panel B). Interestingly,
TREK-1 deficient mice but not WT mice expressed IL-1β at baseline (representative picture
of 4-5 experiments).
Schwingshackl et al. Page 18






















Figure 5. Alveolar macrophages express TREK-1 protein and secrete normal amounts of TNF-α
Isolated alveolar macrophages express TREK-1 protein by immunofluorescence staining
(Panel A). Alveolar macrophages from WT and TREK-1 deficient mice secrete equal
amounts of TNF-α upon LPS stimulation (Panel B); n=5 animals per group.
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Figure 6. HO increased cellular apoptosis in TREK-1 deficient lungs
HO exposure increased the number of apoptotic cells as shown by TUNEL staining in lungs
of TREK-1 ko mice but not in WT mice. Exposure to HO+MV resulted in a further increase
in apoptotic cells in both WT and TREK-1 ko mice, but the effect was more pronounced in
TREK-1 deficient mice. Panel A: green fluorescent, TUNEL positive cells are indicated by
white arrows. Panel B: Quantification of TUNEL positive cells. *compared to untreated WT
control, #compared to untreated TREK-1 ko control, ^comparison between WT and TREK
ko mice within the same treatment group.
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Figure 7. Both type I and type II AECs undergo apoptosis
Double staining of lung sections from TREK-1 deficient mice exposed to HO (Panel A) and
HO+MV (Panel B) using the TUNEL assay and an anti-pro-SPC antibody, or the TUNEL
assay and an anti-Aquaporin-5 antibody (Panel C). Inserts (a) and (b) show TUNEL and pro-
SPC double positive cells representing type II pneumocytes, whereas insert c shows a
TUNEL and Aquaporin-5 double positive cell representing a type I pneumocyte.
Magnification 63×. Images are representative of 4 lung fields from 3 different mice per
group.
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Figure 8. HO exposure induced PARP-1 activation in TREK-1 deficient mice
Panel A shows a representative Western blot showing an increase in cleaved PARP-1 levels
in HO exposed lungs of TREK-1 ko but not WT when compared to untreated mice.
Exposure to HO+MV caused a further increase in cleaved PARP-1 levels in both WT and
TREK-1 ko mice, but the effect was more pronounced in TREK-1 ko mice. Panel B shows
band densitometry analysis of cleaved to total PARP-1 ratios. *compared to untreated WT
control; #compared to untreated TREK-1 ko control; ^comparison between WT and TREK
ko mice within the same treatment group; n=4-7 animals per group.
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